References
1. Al Mheid I, Patel RS, Tangpricha V, Quyyumi AA. Vitamin D and cardiovascular disease: is the evidence solid? Eur Heart J 2013; DOI: 10.1093/eurheartj/eht166.10.1093/eurheartj/eht166Search in Google Scholar PubMed PubMed Central
2. Beveridge LA, Witham MD. Vitamin D and the cardiovascular system. Osteoporosis Int 2013;24:2167–80.10.1007/s00198-013-2281-1Search in Google Scholar PubMed
3. Branderburg VM, Vervolet MG, Marx N. The role of vitamin D in cardiovascular disease: From present evidence to future perspectives. Atherosclerosis 2012;225:253–63.10.1016/j.atherosclerosis.2012.08.005Search in Google Scholar PubMed
4. Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 2012;32:2794–802.10.1161/ATVBAHA.112.248039Search in Google Scholar PubMed
5. Chan WK, Redelmeier DA. Simpson’s paradox and the association between vitamin D deficiency and increased heart disease. Am J Cardiol 2012;110:143–4.10.1016/j.amjcard.2012.02.062Search in Google Scholar PubMed
6. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009;19:73–8.10.1016/j.annepidem.2007.12.001Search in Google Scholar PubMed PubMed Central
7. Li F, Ling X, Huang H, Brattain L, Apontes P, et al. Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene 2005;24:1385–95.10.1038/sj.onc.1208330Search in Google Scholar PubMed PubMed Central
8. Schwartz GG. Approaches to optimizing vitamin D therapy in prostate cancer. J Urol 2011;185:1179–80.10.1016/j.juro.2011.01.041Search in Google Scholar PubMed
9. Liu G, Hu X, Chakrabarty S. Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promote cellular sensitivity to 5-FU. Int J Cancer 2010;126:631–9.10.1002/ijc.24762Search in Google Scholar PubMed
10. Si R, Tao L, Zhang HF, Yu QJ, Zhang R, et al. Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. J Mol Cell Cardiol 2011;50:16–24.10.1016/j.yjmcc.2010.08.017Search in Google Scholar PubMed
11. Li F, Brattain MG. Role of the survivin gene in pathophysiology. Am J Pathol 2006;169:1–11.10.2353/ajpath.2006.060121Search in Google Scholar PubMed PubMed Central
12. Santini D, Abbate A, Scarpa S, Vasaturo F, Biondi-Zoccai GG, et al. Surviving acute myocardial infarctation: survivin expression in viable cardiomyocites after infarction. J Clin Pathol 2004;57:1321–4.10.1136/jcp.2004.018986Search in Google Scholar PubMed PubMed Central
13. Levkau B, Schäfers M, Wohlschlaeger J, von Wnuck Lipinski K, Keul P, et al. Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation 2008;117:1583–93.10.1161/CIRCULATIONAHA.107.734160Search in Google Scholar PubMed
14. Wei L, Wang H, Kuang CY, Zhu JK, Yu Y, et al. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem 2012;363:135–45.10.1007/s11010-011-1166-xSearch in Google Scholar PubMed PubMed Central
15. Deb DK, Chen Y, Zhang Z, Zhang Y, Szeto FL, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-κB pathway. Am J Physiol Renal Physiol 2009;296: F1212–8.10.1152/ajprenal.00002.2009Search in Google Scholar PubMed PubMed Central
©2014 by Walter de Gruyter Berlin Boston